89bio (ETNB) News Today $7.94 +0.91 (+12.94%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period 89bio (NASDAQ:ETNB) Sets New 1-Year Low - What's Next?89bio (NASDAQ:ETNB) Sets New 12-Month Low - Should You Sell?December 20 at 5:04 AM | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 19 at 4:05 PM | globenewswire.com89bio (NASDAQ:ETNB) Shares Down 4.5% - Here's What Happened89bio (NASDAQ:ETNB) Trading Down 4.5% - Here's What HappenedDecember 19 at 1:47 PM | marketbeat.comFmr LLC Purchases 70,129 Shares of 89bio, Inc. (NASDAQ:ETNB)Fmr LLC grew its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 2,153.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 73,386 shares of the company's stock after acquiring an additional 70December 19 at 3:07 AM | marketbeat.comShort Interest in 89bio, Inc. (NASDAQ:ETNB) Increases By 6.5%89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a significant growth in short interest in November. As of November 30th, there was short interest totalling 5,880,000 shares, a growth of 6.5% from the November 15th total of 5,520,000 shares. Based on an average trading volume of 767,600 shares, the days-to-cover ratio is currently 7.7 days.December 17, 2024 | marketbeat.com89bio Strengthens Leadership Retention with New RSUsDecember 16, 2024 | markets.businessinsider.com89bio (NASDAQ:ETNB) Stock Rating Upgraded by Raymond JamesRaymond James raised shares of 89bio to a "strong-buy" rating in a research note on Thursday.December 14, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 5% - What's Next?89bio (NASDAQ:ETNB) Trading Down 5% - Time to Sell?December 13, 2024 | marketbeat.comAnalysts Set 89bio, Inc. (NASDAQ:ETNB) PT at $30.33December 12, 2024 | americanbankingnews.comRohan Palekar Buys 5,000 Shares of 89bio, Inc. (NASDAQ:ETNB) StockDecember 11, 2024 | insidertrades.com89bio, Inc. (NASDAQ:ETNB) CEO Acquires $39,450.00 in Stock89bio, Inc. (NASDAQ:ETNB - Get Free Report) CEO Rohan Palekar acquired 5,000 shares of the stock in a transaction dated Friday, December 6th. The shares were purchased at an average price of $7.89 per share, for a total transaction of $39,450.00. Following the completion of the transaction, the chief executive officer now owns 471,236 shares of the company's stock, valued at $3,718,052.04. This trade represents a 1.07 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.December 10, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Director Charles Mcwherter Acquires 10,000 SharesDecember 10, 2024 | insidertrades.com89bio, Inc. (NASDAQ:ETNB) Director Charles Mcwherter Buys 10,000 Shares89bio, Inc. (NASDAQ:ETNB - Get Free Report) Director Charles Mcwherter purchased 10,000 shares of the firm's stock in a transaction dated Thursday, December 5th. The stock was acquired at an average cost of $8.00 per share, with a total value of $80,000.00. Following the purchase, the director now owns 10,000 shares of the company's stock, valued at approximately $80,000. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.December 9, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. grew its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 186.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 130,894 shares of the company's stock after purchasingDecember 9, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by BrokeragesShares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one hDecember 7, 2024 | marketbeat.com89bio (NASDAQ:ETNB) Sees Large Volume Increase - What's Next?89bio (NASDAQ:ETNB) Sees Unusually-High Trading Volume - Time to Buy?December 6, 2024 | marketbeat.comWhy Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?December 5, 2024 | uk.finance.yahoo.comRedmile Group LLC Reduces Stake in 89bio, Inc. (NASDAQ:ETNB)Redmile Group LLC reduced its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 10.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,569,850 shares of the company's stock after selling 175,806 shaDecember 5, 2024 | marketbeat.comJanus Henderson Group PLC Boosts Holdings in 89bio, Inc. (NASDAQ:ETNB)Janus Henderson Group PLC raised its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 14.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,158,218 shares of the company's stock after buying an additional 1,882,1December 5, 2024 | marketbeat.comHighVista Strategies LLC Invests $494,000 in 89bio, Inc. (NASDAQ:ETNB)HighVista Strategies LLC purchased a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 66,787 shares of the company's stock, valued at approxiDecember 4, 2024 | marketbeat.comErste Asset Management GmbH Acquires New Position in 89bio, Inc. (NASDAQ:ETNB)Erste Asset Management GmbH bought a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 763,000 shares of the company's stock, valued at approDecember 3, 2024 | marketbeat.comWalleye Capital LLC Increases Position in 89bio, Inc. (NASDAQ:ETNB)Walleye Capital LLC increased its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 1,232.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 435,298 shares of the company's stock after acquiring an additional 402,624December 3, 2024 | marketbeat.comPDT Partners LLC Buys New Shares in 89bio, Inc. (NASDAQ:ETNB)PDT Partners LLC purchased a new stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 169,245 shares of the company's stock, valued at approximateDecember 2, 2024 | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 29, 2024 | globenewswire.com89bio to Participate in the 7th Annual Evercore HealthCONx ConferenceNovember 26, 2024 | markets.businessinsider.com89bio, Inc. (NASDAQ:ETNB) CEO Acquires $83,500.00 in StockNovember 26, 2024 | insidertrades.comInsider Buying: 89bio, Inc. (NASDAQ:ETNB) CEO Purchases 10,000 Shares of Stock89bio, Inc. (NASDAQ:ETNB - Get Free Report) CEO Rohan Palekar purchased 10,000 shares of the stock in a transaction dated Friday, November 22nd. The shares were purchased at an average price of $8.35 per share, with a total value of $83,500.00. Following the completion of the acquisition, the chief executive officer now owns 466,236 shares of the company's stock, valued at approximately $3,893,070.60. This represents a 2.19 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.November 25, 2024 | marketbeat.comWestfield Capital Management Co. LP Grows Position in 89bio, Inc. (NASDAQ:ETNB)Westfield Capital Management Co. LP increased its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 29.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,006,038 shares of the cNovember 25, 2024 | marketbeat.com89Bio Inc. Reports Q3 2024 Financial ResultsNovember 21, 2024 | markets.businessinsider.com89bio announces new analyses of data from Phase 2b ENLIVEN trialNovember 15, 2024 | markets.businessinsider.com89bio, Inc. Presents New Data from Phase 2b ENLIVEN Trial of Pegozafermin for Advanced MASH at AASLD 2024November 15, 2024 | quiverquant.com89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024November 15, 2024 | globenewswire.comFY2024 EPS Estimates for 89bio Reduced by Cantor Fitzgerald89bio, Inc. (NASDAQ:ETNB - Free Report) - Analysts at Cantor Fitzgerald dropped their FY2024 earnings estimates for 89bio in a report released on Monday, November 11th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will earn ($2.98) per share for the year, down from their pNovember 14, 2024 | marketbeat.comHC Wainwright Has Pessimistic View of 89bio FY2024 Earnings89bio, Inc. (NASDAQ:ETNB - Free Report) - Stock analysts at HC Wainwright reduced their FY2024 earnings estimates for 89bio in a research report issued on Monday, November 11th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings of ($3.50) per share for the year, downNovember 14, 2024 | marketbeat.com89bio (ETNB) Receives a Hold from OppenheimerNovember 13, 2024 | markets.businessinsider.com89bio announces $100M common stock offeringNovember 13, 2024 | markets.businessinsider.com89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded WarrantsNovember 12, 2024 | globenewswire.com89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded WarrantsNovember 12, 2024 | globenewswire.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have given aNovember 12, 2024 | marketbeat.com89bio’s Pegozafermin: A Promising Best-in-Class Contender in NASH TreatmentNovember 12, 2024 | markets.businessinsider.comPositive Outlook for 89bio Amid Promising Developments in MASH Clinical ProgramsNovember 12, 2024 | markets.businessinsider.com89bio (NASDAQ:ETNB) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $29.00 price target on shares of 89bio in a research note on Monday.November 11, 2024 | marketbeat.comFY2028 Earnings Estimate for 89bio Issued By Leerink Partnrs89bio, Inc. (NASDAQ:ETNB - Free Report) - Leerink Partnrs dropped their FY2028 earnings per share (EPS) estimates for shares of 89bio in a note issued to investors on Thursday, November 7th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings per share of $3.99 for thNovember 11, 2024 | marketbeat.com89bio (ETNB) Gets a Hold from RBC CapitalNovember 10, 2024 | markets.businessinsider.comRaymond James Issues Pessimistic Forecast for 89bio (NASDAQ:ETNB) Stock PriceRaymond James dropped their price objective on shares of 89bio from $53.00 to $49.00 and set a "strong-buy" rating for the company in a research note on Friday.November 8, 2024 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Stock Position Increased by Harbor Capital Advisors Inc.Harbor Capital Advisors Inc. boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 165.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 227,930 shares of the company's stock after bNovember 6, 2024 | marketbeat.com89bio to Participate in the UBS Global Healthcare ConferenceNovember 5, 2024 | globenewswire.com89bio (NASDAQ:ETNB) Shares Gap Down - Should You Sell?89bio (NASDAQ:ETNB) Shares Gap Down - Here's WhyNovember 4, 2024 | marketbeat.comMadrigal, 89Bio jump after Novo’s semaglutide shows promise in MASHNovember 1, 2024 | markets.businessinsider.com89bio (NASDAQ:ETNB) Trading 7.3% Higher - Time to Buy?89bio (NASDAQ:ETNB) Stock Price Up 7.3% - Time to Buy?November 1, 2024 | marketbeat.com Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.570.60▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼64▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Janux Therapeutics News Edgewise Therapeutics News Xenon Pharmaceuticals News Merus News Twist Bioscience News ACADIA Pharmaceuticals News MorphoSys News SpringWorks Therapeutics News Zai Lab News Vericel News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
